Trending Now
Brickell Biotech Inc. (NASDAQ:BBI) To Launch Sofpironium bromide gel, 5% In...
Brickell Biotech Inc. (NASDAQ:BBI) has announced that Kaken Pharmaceutical Co Ltd, its Japanese development partner, will launch ECCLOCK® (sofpironium bromide gel) 5%...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Capricor Therapeutics Inc (NASDAQ: CAPR) Receives Positive Reviews From The Lancet
Capricor Therapeutics Inc (NASDAQ: CAPR) announced that its HOPE-2 Phase II trial had received positive results from The Lancet. The latter has published results...
MAKE IT MODERN
LATEST REVIEWS
Markets in precarious situation heading into volatility
The markets are in a precarious situation right now. We are right off all-time highs and the corona virus is spreading.
MAKE IT MODERN
PERFORMANCE TRAINING
atai Life Sciences (NASDAQ: ATAI) Announce Encouraging Interim Data Showing Pro-Cognitive RL-007 Effects in...
atai Life Sciences (NASDAQ: ATAI) has announced positive preliminary data from the first eight-patient arm of its Phase 2a trial showing the possibility of...
Novan Inc (NASDAQ:NOVN) Phase 3 Clinical Study Of Antiviral Gel – SB206 To Cure...
Novan Inc (NASDAQ:NOVN) commenced a double-blind, multi-center, vehicle-controlled, and randomized Phase 3 clinical study of SB206 to cure molluscum (molluscum contagiosum). It opened clinical...
UNITY Biotechnology Inc. (NASDAQ:UBX) Announces Its Q3 2020 Financial Results And Progress of UBX1325...
UNITY Biotechnology Inc. (NASDAQ:UBX) has announced its Q3 2020 financial results and corporate updates. The company ended the quarter with cash and cash equivalents...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) Doses First Patient on Phase 2b MM-120 Study...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) has announced the dosing of the first patient in the Phase 2b dose-optimization study of MM-120 for Generalized...
Luxury Stocks in Focus as Spending Booms (SIG, SKDI, TPR)
Massive stimulus checks, extreme Fed easing, a strengthening inflationary outlook, rising employment, faster-than-expected vaccine rollout, and the movement out of the cold...
MAKE IT MODERN
